- $257.51m
- $151.24m
- $53.74m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
U.S. STOCKS ON THE MOVE-Merck, Alibaba, BlackRock
U.S. STOCKS ON THE MOVE-Johnson & Johnson, BlackRock, Veradermics
Q32 Bio rises after $200 mln equity raise for hair-loss drug
Brief: Q32 Bio Announces Pricing Of $200 Million Public Offering Of Common Stock And Pre-Funded Warrants
Q32 Bio eases after starting $200 mln equity offering
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology
U.S. STOCKS ON THE MOVE-American Express, Deckers, Q32 Bio
U.S. STOCKS ON THE MOVE-American Express, Deckers, Q32 Bio
Q32 Bio soars as hair-loss drug shows scalp hair regrowth in mid-stage study
U.S. STOCKS ON THE MOVE-Boston Scientific, Banc of California, Salesforce
U.S. STOCKS ON THE MOVE-UnitedHealth, Astrotech, Boston Scientific
NASDAQ RESUMED AT 09:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM